Stocktoria
Carl Zeiss Meditec AG AFX.DE
Carl Zeiss Meditec AG statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€29.60); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Carl Zeiss Meditec AG trades at about 17.9× earnings — below its 10-year norm (10-year range 25.2×–37.2×, median 28.7×).
Shaded band = 10-year range (25.2×–37.2×); dot = today's 17.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 52.8% | 52.7% | 57.7% | 59.3% |
| Operating margin | 10.0% | 9.4% | 16.7% | 20.9% |
| Net margin | 6.3% | 8.7% | 13.9% | 15.4% |
| FCF margin | 6.0% | 4.6% | 6.6% | 5.6% |
| Return on assets | 4.1% | 5.3% | 9.6% | 10.4% |
| Return on equity | 6.7% | 8.8% | 13.4% | 14.6% |
| Current ratio | 2.34 | 2.12 | 3.40 | 3.32 |
Computed from company filings · DE · as of 2025-09-30. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.